TRIASYN 2.5/2.5 tablet blister pack, Sanofi-Aventis Australia Pty Ltd , CON-107
Product name
TRIASYN 2.5/2.5 tablet blister pack
Sponsor name
Sanofi-Aventis Australia Pty Ltd
Consent start
Consent no.
CON-107
Standard
Subsection 11(b) of the Therapeutic Goods Order No. 78 - Standard for Tablets and Capsules.
Non-compliance with standard
The estimated average content of each active ingredient at expiry may be less
than 92.5 per cent of the label claim.
Conditions imposed
The drug product release and expiry specifications are the same as those
currently approved.
Therapeutic product type
Prescription medicines